Related references
Note: Only part of the references are listed.pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens
Jasreet Hundal et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko et al.
CANCER CELL (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
Melinda A. Biernacki et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
Vladimir Roudko et al.
CELL (2020)
Immunogenic neoantigens derived from gene fusions stimulate T cell responses
Wei Yang et al.
NATURE MEDICINE (2019)
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2019)
Tumor neoantigens: from basic research to clinical applications
Tao Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Predicting HLA class II antigen presentation through integrated deep learning
Binbin Chen et al.
NATURE BIOTECHNOLOGY (2019)
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Julien Racle et al.
NATURE BIOTECHNOLOGY (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
Zhiting Wei et al.
ISCIENCE (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri et al.
NATURE MEDICINE (2018)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
Andrew J. Rech et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
Alex Rubinsteyn et al.
FRONTIERS IN IMMUNOLOGY (2018)
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
Rachel Marty et al.
CELL (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery
Jin Zhang et al.
BIOINFORMATICS (2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic et al.
LANCET ONCOLOGY (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Alison M. Schram et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
The neoepitope landscape in pediatric cancers
Ti-Cheng Chang et al.
GENOME MEDICINE (2017)
'Hotspots' of antigen presentation revealed by Human Leukocyte antigen Ligandomics for neoantigen prioritization
Markus Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer
Jennifer L. Kalina et al.
CLINICAL CANCER RESEARCH (2017)
Applications of Immunogenomics to Cancer
X. Shirley Liu et al.
CELL (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
INTEGRATE: gene fusion discovery using whole genome and transcriptome data
Jin Zhang et al.
GENOME RESEARCH (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
Keiichi Ota et al.
CLINICAL CANCER RESEARCH (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Human Structural Variation: Mechanisms of Chromosome Rearrangements
Brooke Weckselblatt et al.
TRENDS IN GENETICS (2015)
The emerging complexity of gene fusions in cancer
Fredrik Mertens et al.
NATURE REVIEWS CANCER (2015)
OptiType: precision HLA typing from next-generation sequencing data
Andras Szolek et al.
BIOINFORMATICS (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Derivation of HLA types from shotgun sequence datasets
Rene L. Warren et al.
GENOME MEDICINE (2012)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Piotr Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma
Ryo Yamamoto et al.
CANCER SCIENCE (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
Crystal L. Mackall et al.
CLINICAL CANCER RESEARCH (2008)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart et al.
BLOOD (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24+ patients with synovial sarcoma
Y Sato et al.
JOURNAL OF IMMUNOLOGY (2002)
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter-institute NIH study
R Dagher et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
J Pinilla-Ibarz et al.
BLOOD (2000)
Share Paper
